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Chapel Hill, North CarolinaABSTRACT Dendritic cells express DC-SIGN, a C-type lectin (CTL) that binds a variety of pathogens and facilitates their
uptake for subsequent antigen presentation. DC-SIGN forms remarkably stable microdomains on the plasma membrane.
However, inner leaflet lipid markers are able to diffuse through these microdomains suggesting that, rather than being densely
packed with DC-SIGN proteins, an elemental substructure exists. Therefore, a super-resolution imaging technique, Blink
Microscopy (Blink), was applied to further investigate the lateral distribution of DC-SIGN. Blink indicates that DC-SIGN, another
CTL (CD206), and influenza hemagglutinin (HA) are all localized in small (~80 nm in diameter) nanodomains. DC-SIGN and
CD206 nanodomains are randomly distributed on the plasma membrane, whereas HA nanodomains cluster on length scales
up to several microns. We estimate, as a lower limit, that DC-SIGN and HA nanodomains contain on average two tetramers
or two trimers, respectively, whereas CD206 is often nonoligomerized. Two-color Blink determined that different CTLs rarely
occupy the same nanodomain, although they appear colocalized using wide-field microscopy. What to our knowledge is a novel
domain structure emerges in which elemental nanodomains, potentially capable of binding viruses, are organized in a random
fashion; evidently, these nanodomains can be clustered into larger microdomains that act as receptor platforms for larger
pathogens like yeasts.INTRODUCTIONImmature dendritic cells are professional antigen presenting
cells that mediate innate and adaptive immune responses by
first detecting and binding to a large variety of pathogens
(1,2). This antigen recognition is driven by interactions of
pathogens with specialized receptors, highly expressed on
the surface of dendritic cells that recognize pathogen-
associated molecular patterns. C-type lectins (CTLs) are
one such family of receptors that recognize carbohydrate
epitopes on the surface of many pathogens (3). One CTL,
DC-SIGN (dendritic cell-specific intercellular adhesion
molecule-3-grabbing nonintegrin), also called CD209, is
a type II membrane protein that binds to a large range of
clinically relevant pathogens, including HIV, Ebola virus,
Candida albicans, and Leishmania (4). DC-SIGN is ex-
pressed in microdomains on the surfaces of dendritic cells
and when ectopically expressed in fibroblasts and other
cell types (5–9). Furthermore, in vitro studies indicate that
DC-SIGN is most probably present as a tetramer on the
plasma membrane (10–16). Recognition of and binding to
pathogens by DC-SIGN appears to require that theSubmitted September 23, 2011, and accepted for publication February 13,
2012.
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0006-3495/12/04/1534/9 $2.00presumed DC-SIGN tetramers, or at least DC-SIGN as
a monomer, be clustered on the plasma membrane (5).
DC-SIGN forms clusters on the cell surface even in the
absence of exogenous ligands and these clusters enable
DC-SIGN to bind to pathogens ranging in size from viruses
(typically 80–100 nm in diameter) to yeast particles (several
microns in diameter). In fact, previous measurements using
wide-field microscopy methods have indicated that DC-
SIGN microdomains both on human immature dendritic
cells and on fibroblasts ectopically expressing DC-SIGN
range in size from that detectable by classical optical reso-
lution (z300 nm) to ~1.5 mm in dimension (8). Other work,
using transmission electron microscopy (TEM) and near-
field scanning optical microscopy (NSOM), has indicated
that DC-SIGN clusters are generally <200 nm in diameter
(5–7). Recent results using several complementary fluores-
cence imaging-based techniques to measure the lateral
dynamics of DC-SIGN microdomains indicated that these
microdomains are remarkably stable (8,9). However,
fluorescence recovery after photobleaching experiments
determined that lipids can permeate and diffuse through
DC-SIGN microdomains (9), suggesting that, rather than
being densely packed with DC-SIGN proteins, there may
be a complex internal structure to DC-SIGN microdomains
that are viewed as continuous structures using wide-field
fluorescence microscopy. Throughout this work, we will
refer to domains observable by wide-field fluorescence
microscopy, having a resolution limit of ~300 nm, as
microdomains, whereas domain structures with dimensiondoi: 10.1016/j.bpj.2012.02.022
Blink Microscopy on DC-SIGN Nanodomains 1535~100 nm or less, which are only observable by super-resolu-
tion methods, will be referred to as nanodomains.
The studies reported in this work describe results obtained
by using a super-resolution imaging technique, Blink
Microscopy (Blink), to examine the nanostructure of DC-
SIGN microdomains on fixed dendritic cells. Blink is one
of several recently developed methods that use sequential,
sparsely distributed single-molecule imaging to generate
plots of precise locations of single molecules, with a resolu-
tion of ~30 nm (17). This method employs oxidation and
reduction agents to drive the majority of the dyes into tran-
sient dark states, with only a few sparsely distributed dyes
fluorescing, with ms-long on times, at a time. Blink offers
several advantages for biological applications because it
permits the use of commercial dyes (and therefore doesn’t
require overexpression of a fluorescent protein fusion), it
uses fast (<120 s) times for image acquisition (2–4000
frames at 30 ms integration times), and is experimentally
simple to setup (requiring only the use of standard immunos-
taining practices and the exchange of soluble buffers).
However, as withmany of the other super-resolution imaging
methods, Blink is most effective when imaging fixed cells
using total internal reflection fluorescence (TIRF) micros-
copy, and therefore can be most easily applied to image
proteins at or very near the ventral cell surface or coverslip.
For comparative purposes, the distribution of DC-SIGN at
suboptical resolution was complemented by observations of
another protein, influenza hemagglutinin (HA). HA is
located in the viral envelope, but also forms plasma
membrane microdomains when ectopically expressed in
noninfected cells. The propensity for HA to form microdo-
mains on plasma membranes is presumably related to subse-
quent viral budding (18,19). Analysis of Blink images
determined that DC-SIGN and HA are predominantly
expressed in small nanodomains, ~80 nm in diameter.
However, although statistical analyses showed that DC-
SIGN nanodomains are randomly distributed on dendritic
cell surfaces, the same analyses indicated that HA nanodo-
mains are not randomly distributed on NIH 3T3 HAb2
cell surfaces at length scales up to and beyond 1 mm. Finally,
the number of Blink localizations per nanodomain indicated
that DC-SIGN andHAnanodomains generally contain fewer
than 12 molecules, suggesting that these nanodomains are
not densely packed with DC-SIGN or HAmolecules, respec-
tively, leaving room for other protein and lipid components.
To determine whether the spatial arrangement of DC-
SIGN is representative of other members of the CTL family
of proteins, Blink was applied to investigate the lateral
distribution of another CTL family member, CD206.
Analysis of Blink images indicated that, similar to DC-
SIGN, CD206 is also generally expressed in randomly
distributed, small (<80 nm in diameter) nanodomains.
However, CD206 nanodomains appear to contain fewer
molecules on average than DC-SIGN and HA nanodomains.
Furthermore, two-color Blink imaging determined thatdifferent CTLs (DC-SIGN and CD206) are generally
confined to separate nanodomains and rarely coexists within
the same nanodomain, though when viewed by wide-field
microscopy they appear to be colocalized.
Overall, the results reported here indicate that there is a
lateral organization of nanodomains within DC-SIGN and
CD206 microdomains, which cannot be resolved by wide-
field fluorescence microscopy; give a considerable amount
of quantitative insight with respect to this complexity; and
raise key questions concerning structure-function relation-
ships for certain classes of membrane receptor clusters.MATERIALS AND METHODS
Due to space constraints, this section is described in full detail in the
Supporting Material.RESULTS
Blink on DC-SIGN plasma membrane
nanodomains
DC-SIGN forms remarkably stable microdomains on the
plasma membrane that range in size, as estimated from
wide-field fluorescence microscopy, from the diffraction
limit to ~1.5 mm in dimension (8,9). However, inner leaflet
lipid markers are able to diffuse through these microdo-
mains suggesting that rather than being densely packed
with DC-SIGN proteins, an elemental substructure exists
(9). Therefore, a super-resolution imaging technique, Blink
(17), was applied to further investigate the lateral distribu-
tion of DC-SIGN within microdomains on the plasma
membrane. Blink achieves subdiffraction limited resolution
by precisely localizing single molecules that are stochasti-
cally imaged in a sequential manner so that no more than
one molecule is actively emitting fluorescence within the
point spread function of the molecule (20).
Before antibody staining and imaging, all cells were fixed
by using a paraformaldehyde solution (4% (w/v) in phos-
phate buffered saline (PBS), pH 7.4) for 20 min at 25C
and then maintained in 0.1% (w/v) bovine serum albumin
in PBS overnight at 4C. Fixed monocyte-derived immature
dendritic cells were stained for DC-SIGN using indirect
immunofluorescence with DC6 IgG and ATTO655-Fab.
Blink images were generated from movies taken while the
dyes were induced to blink with ms-long on-times in the
presence of reducing and oxidizing agents. Specifically,
cells labeled with primary and secondary antibodies were
imaged in PBS containing both 50–100 mM ascorbic acid
and 0–75 mM N,N-methylviologen. Ascorbic acid and
N,N-methylviologen concentrations were adjusted to gain
sufficient localizations within 120 s. Each point in a Blink
image represents the precise location of a single molecule
given by fitting the spatial distribution of the fluorescence
from a single molecule to a Gaussian function. Fig. 1 showsBiophysical Journal 102(7) 1534–1542
FIGURE 1 Blink on DC-SIGN plasma membrane nanodomains. (A)
Image of DC-SIGN expression on a fixed dendritic cell stained with DC6
and anti-mouse ATTO655-Fab using diffraction limited TIRF illumination.
(B) Super-resolution Blink image of DC-SIGN expression of the same
region in A. (C) Overlay of TIRF image (in red) and Blink image (in white).
Scale bars, 500 nm; scale bar inset, 100 nm.
1536 Itano et al.a representative image (one of 17 images analyzed): Fig. 1 A
gives the conventional TIRF image; Fig. 1 B gives the Blink
image; and Fig. 1 C gives an overlay of the Blink image
and the TIRF image. It can be readily seen by comparing
Fig. 1, A and B, Blink provides a much higher resolution in
terms of localizing centroids of DC-SIGN micro/nanodo-
mains in the same region of the cell. For example, in some
cases where a single region of fluorescence or microdomain
is viewed using TIRF, the Blink image indicates that this
area is actually composed of several very small nanodomains
(Fig. 1 C, inset). Additionally, the TIRF image (Fig. 1 A) and
the corresponding computer-generated convolution of the
Blink image to a corresponding wide-field image (Fig. S1
in the Supporting Material) are very similar. Nonetheless,
these two images are not completely identical. Most of the
variation is due to differences in relative pixel intensity
values between the two images, because the values in
Fig. 1 A reflect actual fluorescence intensities, whereas the
values in Fig. S1 were generated computationally. In addi-
tion, the number of Blink localizations within a pixel area
should be, for the most part, correlated with the number of
fluorophores in the area, but will also depend on the specificBiophysical Journal 102(7) 1534–1542blinking properties during the imaging conditions (e.g.,
how long given fluorophores were in the on-state), possible
differences in photobleaching, and the likelihood that more
than one fluorophore within the point spread function at
a given location is in an on-state at the same time. Further-
more, there are some areas in the TIRF image (A) that do
not appear in either the Blink image (B) or the Blink image
following convolution (Fig. S1); most likely because the
TIRF image is taken at the beginning of the movie (when
all fluorophores are in the on-state), but subsequently some
of the fluorophores irreversibly photobleach and are not
able to be detected by Blink.Size estimation of DC-SIGN plasma membrane
nanodomains using Blink
Blink images of DC-SIGN on fixed dendritic cells stained
with DC6 and anti-mouse ATTO655-Fab allowed visuali-
zation of small DC-SIGN nanodomains on the plasma
membrane. To determine the range in sizes of these nanodo-
mains, the Blink images were analyzed using ImageJ and
custom-built Labview software. Nanodomains were first
identified using the Particle Analyzer routine in ImageJ
(Fig. 2). The spatial distributions of Blink localizations in
each nanodomain were then fit to two-dimensional Gaussian
functions and the full width at half-maximum (FWHM)
values, of the fitted Gaussian functions, were used to
estimate nanodomain diameters (Fig. 2). The average
FWHM for DC-SIGN nanodomains was 76 5 42 nm
(mean 5 standard deviation for 3706 FWHM measure-
ments, derived from 1853 nanodomains on 17 cells; Table
1 and Fig. 3). It is notable that the majority of the DC-
SIGN nanodomains are smaller than 100 nm in diameter
(Fig. 3), which is significantly less than the ~500 nm micro-
domain dimension observed in TIRF and epifluorescence
images (Fig. 1 A and (8)). These results are consistentFIGURE 2 Determining DC-SIGN nanodomain
size using Blink. Super-resolution Blink image of
DC-SIGN expression on a fixed dendritic cell
stained with DC6 and anti-mouse ATTO655-Fab.
The density of Blink localizations is denoted
with black being least dense and white being
most dense. Scale bar, 500 nm. A close-up view
of the Blink localizations in a single DC-SIGN
nanodomain, highlighted in the white box, appears
to the right of the original image (scale bar, 50 nm).
A graph showing the distribution of the Blink
localizations in the nanodomain in the x dimension
appears above the Blink image of the single nano-
domain, and the Gaussian fit along the x axis is
shown with the black line. The data in the y dimen-
sion are depicted in the graph in a vertical orienta-
tion to the right of the Blink image of the single
nanodomain, and the Gaussian fit along the y axis
is shown with the red line.
TABLE 1 Characteristics of DC-SIGN, CD206, and HA nanodomains as measured by Blink Microscopy
DC-SIGN domains CD206 domains
Mean (median) Range n (m) Mean (median) Range n (m)
Overall FWHM (nm) 765 42 (66) 20–991 3706 (17) 705 41 (59) 17–300 2819 (13)
Area (nm2) 51005 6100 (3300) 670–80814 1853 (17) 44005 4700 (2800) 360–45247 1409 (13)
Number of Blink localizations 1635 230 (82) 8–2283 1960 (17) 785 168 (24) 5–2357 1409 (13)
HA domains Single ATTO655-Fabs
Mean (median) Range n (m) Mean (median) Range n (m)
Overall FWHM (nm) 745 47 (61) 24–486 2910 (12) 395 11 (38) 24–91 191 (6)
Area (nm2) 52005 7800 (2900) 559–90554 1455 (12) 12005 580 (1200) 553–3285 97 (6)
Number of Blink localizations 1205 142 (71) 11–1688 1099 (12) 255 18 (22) 5–111 97 (6)
Uncertainties are standard deviations. Parameters m and n are the numbers of images and nanodomains analyzed, respectively.
Blink Microscopy on DC-SIGN Nanodomains 1537with those from other studies using methods with high
spatial resolution, TEM and NSOM, which have also
determined that DC-SIGN is predominantly localized in
domains <200 nm in diameter (5–7). However, the DC-
SIGN nanodomains imaged by Blink are slightly smaller
on average than those that were previously analyzed
using these other techniques. For the NSOM measurements,
the average DC-SIGN domain size (~100 nm) was at the
lower limit of spatial resolution for this method (90–
100 nm). Furthermore, the relatively large (10 nm) gold
particles used for labeling antibodies for the TEM experi-
ments may have resulted in slightly larger domain size
measurements.FIGURE 3 Size estimation of DC-SIGN, CD206, and HA plasma
membrane nanodomains using Blink. FWHM values obtained by Blink
of single ATTO655-Fab molecules (black bars), DC-SIGN nanodomains
on dendritic cells stained with DC6 and anti-mouse ATTO655-Fab (blue
bars), CD206 nanodomains on dendritic cells stained with AF2534 and
anti-goat ATTO655-Fab (green bars), and HA nanodomains on HAb2 cells
stained with FC125 and anti-mouse ATTO655-Fab (red bars). As shown,
DC-SIGN, CD206, and HA nanodomains all have similar size distributions.
The average nanodomain size is much larger than the spatial accuracy of the
method as determined by imaging single ATTO655-Fab molecules and is
much smaller than the conventional wide-field fluorescence microscopy
resolution limit.Comparison of size estimation of DC-SIGN
plasma membrane nanodomains to those
of influenza HA and CD206, another
C-type lectin, using Blink
Although the results presented thus far have primarily
focused on describing the spatial distribution of DC-
SIGN, work focused on describing heterogeneity on the
plasma membrane and the downstream consequences of
such molecular assemblies has become an issue of consider-
able interest. Influenza HA domains, when HA is ectopi-
cally expressed, have been investigated by different
imaging modalities (21,22), and, therefore, it is useful to
compare our results from DC-SIGN to those from HA.
HA is a glycoprotein that is expressed on the envelope of
influenza viruses and is required for the virus to bind to
and be internalized either by target cells for infection
or by immunological cells for antiviral immunity (23). On
virally infected cells, HA assembles into plasma membrane
domains, presumably at sites of subsequent viral budding
from the cell surface (18,19). When HA is ectopically
expressed in fibroblasts, without other viral proteins, HA
appears to accumulate into domains (ranging from 30 nm
to several microns in diameter) on the plasma membrane
of fixed and live cells (18,21,22). Consistent with these
previous findings, Blink on fixed HAb2 cells, a NIH 3T3cell line that stably expresses HA, indicates that the protein
is distributed in clusters on the cell surface. The size distri-
bution of these clusters was analyzed using the same method
described previously for DC-SIGN. Similar to the distribu-
tion of DC-SIGN, HA is expressed in small nanodomains,
the majority of which are <100 nm in diameter (2910
FWHM measurements derived from 1455 nanodomains on
12 cells; Table 1 and Fig. 3). These nanodomains of HA
were similar in dimension to the compact clusters described
by Hess et al. (21); however, because our analysis did not
include the cell borders, we did not analyze the elongated
clusters observed earlier.
Additionally it is useful to compare the clustering of DC-
SIGN to that of another CTL family member, CD206, to
investigate whether the spatial arrangement of DC-SIGN
is representative of other members of the CTL family of
proteins. Previously, it was determined that CD206 was
also expressed in microdomains on the plasma membraneBiophysical Journal 102(7) 1534–1542
1538 Itano et al.of dendritic cells, and that these microdomains sometimes
colocalized with DC-SIGN microdomains (9). Blink on
fixed dendritic cells stained with AF2534 and anti-goat
ATTO655-Fab determined that CD206 is also expressed in
nanodomains, which are 70 5 41 nm in diameter (2819
FWHM measurements, derived from 1409 nanodomains
on 13 cells; Table 1 and Fig. 3). This result suggests that
other CTLs may also have distinct nanoscale architecture.Estimated localization precision of Blink by
imaging single ATTO655-Fab molecules on glass
Similar to other super-resolution imaging techniques that
use stochastic activation of fluorophores, each dye imaged
by Blink is typically localized multiple times (fit to
Gaussian functions in multiple frames) in the final Blink
image. Therefore, although the localization precision of
a single dye in a single frame depends on the number of
photons collected (24), the localization precision of a single
dye in a Blink image is also related to the spatial distribution
of all of the Blink localizations derived from a single dye.
To determine localization precision including the influence
of multiple localizations of single dyes, Blink images of
sparsely distributed single anti-mouse ATTO655-Fab mole-
cules on glass were analyzed. Based on the number of
bleaching steps for many individual ATTO655-Fabs, the
average dye/protein ratio was determined to be 1.4
(Fig. S2). The average FWHM of the Gaussian fits to the
distributions of Blink localizations from single ATTO655-
Fabs on glass was 395 11 nm (191 FWHMmeasurements,
97 dyes; Table 1). It is notable that the average FWHM
measurements for DC-SIGN and HA nanodomains are
significantly larger than the localization precision for a
single fluorescent Fab (Fig. 3); therefore, it is highly
unlikely that the FWHM measurements of DC-SIGN are
of single Fabs, and much more likely that the FWHM
measurements refer to the dimensions of DC-SIGN nanodo-
mains on the plasma membrane.DC-SIGN and CD206, but not HA, nanodomains
are randomly distributed on the plasma
membrane
Blink provides high-resolution spatial distribution data,
which allows mapping of the precise locations (or centroids)
of nanodomains and makes possible discrimination between
whether DC-SIGN and CD206 nanodomains are randomly
or nonrandomly distributed on the cell surface. Using the
PAST (25) and the Cellspan (26) analysis programs,
Ripley’s K and modified Hopkin’s tests were applied to
the distributions of nanodomain centroids from Blink
images that were cropped to exclude cell boundaries and
areas not covered by a cell, respectively. In the case of the
Ripley’s K test, the PAST program was used to calculate
the function K(r), which indicates the probability of encoun-Biophysical Journal 102(7) 1534–1542tering another centroid at the length scale denoted on the
r axis. For random distributions the function K(r) is propor-
tional to the density of the centroids and pr2. Red lines in the
plots (Fig. 4, C, F, I) represent the 95% confidence interval
for complete spatial randomness calculated from 1000
Monte Carlo simulations of randomly distributed points
for each image. Clustering is indicated at length scales
where K(r) is greater than that expected due to a random
distribution of points. Cellspan’s modified Hopkin’s test
for spatial randomness compares the distances between
random data points and nanodomain centroids to the
actual distances between nanodomain centroids. A random
distribution is indicated by a function that is shaped like
a normal bell curve centered at the Hopkin’s statistic
0.5 on the abscissa. Clustering is indicated if the plot is
shifted to the right. For both of these analyses, the distribu-
tion of DC-SIGN and CD206 nanodomain centroids
aligns closely with the expected result for a random distri-
bution (Fig. 4, A–F). This finding agrees with the NSOM
data (6).
Very different results were obtained when the same anal-
ysis methods were applied to centroids derived from Blink
images of HA (Fig. 4, G–I). For every HA image analyzed
(12 of 12 images), the modified Hopkin’s test indicated
clustering and the Ripley’s K test indicated clustering of
multiple nanodomains across all length scales up to 1 mm.
For the Ripley’s K test, clustering is indicated by the K(r)
statistic being greater than the value expected for a random
distribution at the length scales indicated by the values on
the abscissa. The K(r) statistic for HA nanodomain centroids
was consistently greater than the parabolic curve expected
for a random distribution from the shortest distances meas-
ureable (~30 nm) to >1 mm. In many cases, the Ripley’s
K test indicated clustering for even longer distances. These
results are consistent with previous analysis of the distribu-
tion of HA using electron microscopy and fluorescence pho-
toactivation localization microscopy (21). These results also
indicate that the assembly and/or the maintenance of DC-
SIGN and CD206 nanodomain distributions on the cell
surface are regulated by distinct mechanisms from those
that occur with HA nanodomains.Estimated occupancy of DC-SIGN in single
nanodomains using Blink
Because the number of Blink localizations in a DC-SIGN
nanodomain is, on the average, proportional to the number
of molecules in the nanodomain, it is possible to estimate
the occupancy of DC-SIGN in nanodomains using data
derived from Blink images of DC-SIGN on fixed dendritic
cells. A single molecule, in this case a single Fab, will blink
with a characteristic rate, leading to an average number of
Blink localizations that will be derived from a single Fab
imaged with consistent experimental conditions. The
average number of Blink localizations from a single Fab
FIGURE 4 DC-SIGN and CD206, but not HA,
nanodomains are randomly distributed on the
plasma membrane. (A, D and G) Binarized super-
resolution Blink images (cropped to exclude cell
borders) of DC-SIGN expression on dendritic cells
stained with DC6 and anti-mouse ATTO655-Fab
(A), of CD206 expression on dendritic cells stained
with AF2534 and anti-goat ATTO655-Fab (D), or
of HA expression on HAb2 cells stained with
FC125 and anti-mouse ATTO655-Fab (G); these
images are representative of a collection of 16,
13, and 12 analyzed for DC-SIGN, CD206, and
HA, respectively. (B, E, and H) Results of a modi-
fied Hopkin’s test for spatial randomness on
centroids of DC-SIGN (B), CD206 (E), or HA
(H) nanodomains (in blue) from the images in A,
D, and G, respectively. The distribution expected
if the centroids were distributed randomly is de-
picted with the red lines. A nonrandom distribution
or clustering would be indicated by a shift in the
distribution to the right. (C, F, and I) Results
from a Ripley’s K test for spatial randomness on
centroids of DC-SIGN (C), CD206 (F), or HA (I)
nanodomains (black lines) from the images in A,
D, and G, respectively. The red lines indicate the
95% confidence interval for complete spatial
randomness calculated from 1000 Monte Carlo
simulations of random distributions of centroids.
Scale bars, 500 nm.
FIGURE 5 Estimated occupancy of DC-SIGN, CD206, and HA in single
nanodomains using Blink. (A) Histogram of the number of Blink localiza-
tions for single ATTO655-Fab antibodies on glass (black bars), single DC-
SIGN nanodomains on dendritic cells stained with DC6 and anti-mouse
ATTO655-Fab (blue bars), CD206 nanodomains on dendritic cells stained
with AF2534 and anti-goat ATTO655-Fab (green bars), and HA nanodo-
mains on HAb2 cells stained with FC125 and anti-mouse ATTO655-Fab
(red bars). (B) Histogram of the minimum number of DC-SIGN molecules
per nanodomain on dendritic cells (blue bars), of CD206 molecules per
nanodomain on dendritic cells (green bars), and of HA molecules per nano-
domain on HAb2 cells (red bars). Minimal occupancies for each nanodo-
main type were determined by dividing the number of Blink localizations
per nanodomain by the average number of Blink localizations for a single
Fab on glass.
Blink Microscopy on DC-SIGN Nanodomains 1539was 255 18 (97 dyes analyzed; Table 1, Fig. 5 A). There is
variability in the number of Blink localizations from single
Fabs as different molecules may have zero, one, two, or
perhaps even three conjugated fluorophores (Fig. S2). In
addition, the blinking of each dye is a stochastic process
sometimes leading to the dye having slightly longer or
shorter on-times during the imaging process, leading to
more or fewer blink localizations per single dye in a given
blink image. Using the same laser power, camera integration
time, concentrations of antibodies, and analysis conditions,
the average number of Blink localizations from a single
DC-SIGN nanodomain was found to be 163 5 230 (1960
nanodomains analyzed; Table 1, Fig. 5 A). As shown in
Fig. 5 A and indicated by the large standard deviation of
the measurement, there is a large variability in the number
of Blink localizations from single DC-SIGN nanodomains.
The total number of Blink localizations in a single nanodo-
main is equal to the sum of Blink localizations from all of
the single molecules in the nanodomain. Therefore, an esti-
mate of the occupancy of DC-SIGN in single nanodomains
was calculated by dividing the number of Blink localiza-
tions in a single nanodomain by the average number of
Blink localizations from a single dye. The majority of
both DC-SIGN and HA nanodomains contain fewer than12 molecules (7 5 10 and 5 5 6, 1960 and 1099 nanodo-
mains analyzed, respectively) with a few nanodomains
(<100 nm in diameter) of each type accommodating upwardBiophysical Journal 102(7) 1534–1542
FIGURE 6 DC-SIGN and CD206 plasma membrane nanodomains are
usually spatially distinct. Overlay image of DC-SIGN (green) and CD206
(red) expression on a dendritic cell stained with DCN46, anti-mouse
Alexa546, AF2534, and anti-goat ATTO655-Fab using two-color Blink.
Regions in yellow boxes are shown at higher magnification to the right
and show examples of significant overlap (top), minor overlap (middle),
and no overlap (bottom); the latter is the most prevalent situation by far.
Scale bar, 500 nm; scale bars insets, 100 nm.
1540 Itano et al.of ~65 molecules (Table 1, Fig. 5 A). CD206 nanodomains,
on the other hand, appear to contain fewer molecules on
average, with a larger population of what appear to be
single, nonoligomerized molecules on the cell surface
(1409 nanodomains analyzed; Table 1, Fig. 5 A). Given
the average diameter of the ectodomain of a tetramer of
DC-SIGN of ~8 nm (27,28), we calculated that ~360 mole-
cules of DC-SIGN or ~90 tetramers could fit within a nano-
domain of average size (~76 nm in diameter; Table 1).
However, we regard the nanodomain occupancy estimate
as a lower limit for the following reasons: 1), a portion
of the population of labeling Fabs will bind but have
no dye conjugated to them; 2), whether, at saturation
binding conditions for the primary antibody, every DC-
SIGN can be labeled due to steric hindrance between adja-
cent binding antibodies; and 3), whether one bivalent
primary antibody can bind two proximate DC-SIGN
molecules. Nevertheless, even if the average number of
DC-SIGN molecules in nanodomains was underestimated
by a factor of two to three, the nanodomain would not
be fully occupied by close packed DC-SIGN proteins (see
Fig. 7).DC-SIGN does not significantly colocalize
with CD206 on the nanoscale
Wide-field fluorescence microscopy indicates that in
a significant fraction of cases, Dectin-1 or CD206 colocalize
with DC-SIGN on the resolution level of the light micro-
scope (9). Whether this result holds on the nanoscale has
important implications for membrane function. It is likely
that whether CTLs are separated into different elemental
nanodomains and/or co-mingled in the same nanodomain
will regulate their downstream signaling (i.e., either by
segregating downstream enzymes and substrates or by
providing coincidence of two pathways both impinging
on common downstream targets). Two-color Blink using
ATTO655 and Alexa546 to label the two different secondary
atnibodies was applied to test whether DC-SIGN and
CD206 are colocalized on the nanoscale (Fig. 6, Fig. S3).
To optimize the blinking of both fluorophores for two-color
measurements, some cells were imaged in an alternative
solution that achieved oxygen removal enzymatically (2%
glucose in PBS with 50 mg/ml glucose oxidase, 100–200
mg/ml catalase, 0.1 mM TCEP-HCl (Sigma, Deisenhofen,
Germany), and contained 1–50 mM cysteamine (MEA,
Sigma) as a reducing agent. Approximately the same %
colocalization is calculated for both the two-color Blink
images (20 images analyzed) and for simulated images
(100 images analyzed) of two overlapping randomly distrib-
uted sets of nanodomains (3.4 5 1.9 and 1.9 5 0.1%,
respectively, Fig. S3). This super-resolution imaging deter-
mined that these two different CTLs are generally confined
to separate nanodomains, and rarely coexist within the same
nanodomain.Biophysical Journal 102(7) 1534–1542DISCUSSION
How certain receptors are laterally organized on the
membrane to enable binding to a large variety of potential
ligands, and the interactions of these receptors with other
membrane proteins and lipids that enable downstream
signaling and internalization, remains a significant open
question in biology. DC-SIGN, a CTL, forms clusters on
the plasma membrane and these clusters subsequently
bind to a diverse range of pathogens, ranging in size, surface
composition, and infection route (4,5). The specific manner
in which DC-SIGN clustering enables the receptor to bind to
such pathogens is under active investigation (29–33). In this
work, we have investigated the distribution of DC-SIGN and
another CTL, CD206, on dendritic cells using a super-
resolution imaging technique, Blink, which has a positional
precision (FWHM) for a single dye on glass of ~40 nm. For
reference, Blink was also used to image HA expressed on
murine fibroblasts.
Blink indicates that DC-SIGN and CD206 are organized
into ~80 nm nanodomains on the surface of dendritic
cells that cannot be resolved by wide-field fluorescence
microscopic methods. Thus, super-resolution (34,35) and
ultrastructural methods (5) are required to reveal this unex-
pected substructure. Interestingly, the viral influenza HA
protein, which forms dynamic clusters on the plasma
membrane during viral budding, is also organized in
~80 nm nanodomains on the surface of a stable cell line
that ectopically expresses HA. However, the overall lateral
distribution of CTLs (DC-SIGN and CD206) and HA nano-
domains in the plane of the plasma membrane differs
Blink Microscopy on DC-SIGN Nanodomains 1541greatly. In the case of DC-SIGN and CD206, nanodomains
are randomly distributed on the cell surface, whereas, in the
case of HA, the nanodomains are clustered on length scales
up to, and sometimes beyond, 1 mm, consistent with earlier
studies (21). Moreover, HA can exchange between its
microdomains and the surrounding membrane on a rapid
timescale; DC-SIGN does not exchange on timescales
over several minutes (9). In the case of HA, which must
assemble into domains capable of enclosing virions of
~100 nm in diameter, the propensity to cluster and to be ex-
pressed in a specific lipid environment may be selecting
for a nonrandom distribution of clusters across the cell
surface.
Furthermore, because Blink is based upon the sequential
localizations of single dyes used for immunofluorescent
labeling, it is possible to estimate the occupancy of DC-
SIGN in nanodomains. This calculation is accomplished
by dividing the number of Blink localizations per nanodo-
main by the average number of Blink localizations for
a single Fab. This analysis estimates that a DC-SIGN nano-
domain contains on average, and as a lower bound, 1–3
tetramers, suggesting both that DC-SIGN is not densely
packed within nanodomains (Fig. 7) and that other proteins
and lipids occupy such nanodomains. Thus, in the absence
of ligand, DC-SIGN receptors are organized to have a 4-
to 12- fold increased valency, at a minimum, compared to
a single receptor. This multivalency, in combination with
the extreme lateral stability of the microdomains (8,9),
may allow the nanodomains to more effectively interact
with weakly binding antigen. Interestingly, it has been
proposed that only a single HIV-1 Env (envelope glycopro-
tein) trimer is capable of initiating viral entry (36). Further-
more, two-color Blink determined that microdomains
that appear by wide-field microscopy to contain multiple
CTLs are composed of discrete nanodomains containingFIGURE 7 Model of occupancy of DC-SIGN in single nanodomains.
A schematic depicting the distribution of DC-SIGN tetramers in a single
DC-SIGN nanodomain on a dendritic cell. If the entire area of ~76 nm in
diameter nanodomain was occupied by DC-SIGN tetramers (~8 nm in
diameter (27,28)), one would expect ~90 tetramers to be in a single nano-
domain. However, data using the super-resolution Blink imaging method
indicates that, as a lower limit, as few as 1–3 tetramers occupy a single
DC-SIGN domain, leaving room for many other receptors and lipids to
co-occupy the nanodomains.only one type of CTL that are positioned close to one
another.
Our results raise a number of important questions for the
manner in which DC-SIGN and other CTLs carry out their
biological function, and also provide, to our knowledge,
new information that will be useful for understanding the
relationship between composition, structure, and dynamics
for other clusters of plasma membrane receptors in cell
biology. First, will the disposition of some membrane
proteins (e.g., DC-SIGN and CD206) into elemental
nanodomains prove to be a paradigm for certain classes of
receptors? Second, what other components reside in the
DC-SIGN and CD206 nanodomains and how are these
nanodomains stabilized? For DC-SIGN, these questions
are particularly intriguing because microdomain stability
appears not to depend directly on the presence of the
cytoplasmic domain but rather on the ectodomain of the
protein (9,37). Third, from an immunological point of
view, how does the distribution of DC-SIGN nanodomains
adjust to accommodate large and small pathogens with
different glycan patterns on their surfaces? Answers to these
questions will substantially increase our understanding of
membrane domain structures, their relation to function
and, in the case of DC-SIGN and other CTLs, perhaps
provide clues for the design of new therapeutic agents for
human infectious diseases.SUPPORTING MATERIAL
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